Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Inhaled GB002 for the Treatment of World Health Organization Group 1 Pulmonary Arterial Hypertension
| Autor: | Frantz, R., Howard, L.S., McLaughlin, V.V., Sitbon, O., Zamanian, R.T., Benza, R.L., Chin, K., Channick, R.N., Cravets, M., Bruey, J., Roscigno, R., Mottola, D., Zisman, L.S., Ghofrani, H. |
|---|---|
| Zdroj: | In Journal of Heart and Lung Transplantation April 2021 40(4) Supplement:S107-S107 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|